BioSpace News Archive

Prime Therapeutics LLC’s President and CEO Ken Paulus is joining over 2,000 other chief executive officers by signing the CEO Action for Diversity & Inclusion pledge.

HanAll Biopharma (KRX: 009420) (HanAll) announced on the 29th, Apr. that it achieved 27.8 billion won in sales, 5.4 billion won in operating profit and 4.5 billion won in net profit in the first quarter of this year.

Novarad, a leader in transformative imaging technologies, announced that its COVID-19 AI Diagnostic Assistant has been selected as the winner of the “Best New Radiology Solution” award in the fifth annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market.

Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, announced that its Nerivio® therapeutic wearable has been selected as the winner of the “Best New Technology Solution for Pain Management” award in the fifth annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough.

Viome, a mission-driven bioscience company focused on helping individuals improve their health, today announced its proprietary mRNA analysis technology combined with its next-generation AI platform has been designated a Breakthrough Device by The Food and Drug Administration (FDA) for early detection of oral cancer and throat cancer.

Infor, the industry cloud company, announced that Penn Highlands Healthcare, a six-hospital integrated health system in northwestern Pennsylvania, has selected Infor CloudSuite Healthcare and Infor Cloverleaf Cloud to move forward its future vision.

Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced that it has finalized an advance purchase agreement with Gavi, the Vaccine Alliance for supply of its recombinant protein-based COVID-19 vaccine candidate to the COVAX Facility.

Dr. Kevin J. Tracey, bioelectronic medicine pioneer and president and CEO of the Feinstein Institutes, will oversee the multi-year study

Elligo Health Research, a leading integrated research organization that accelerates decentralized trials through healthcare, announced its partnership with N. Harris Computer Corporation through its Sidus Insights, Inc. subsidiary.

Following a year of global uncertainty, ANRF emerges on solid footing and provides new funding for research in multiple disease areas.